Courtney Beers
Patrimonio netto: 4 208 $ in data 31/07/2026
Patrimonio netto: 4 208 $ in data 31/07/2026
Courtney Beers is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022 and Chief Scientific Officer at Tizona Therapeutics, Inc. since 2019.
Formerly, Dr. Beers was Head of Cancer Immunotherapy at Cascadian Therapeutics LLC.
Dr. Beers earned a doctorate from the University of Washington.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 57.650 ( 0,01% ) | 4 208 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/12/2022 |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Direttore Tecnico/Scientifico/R&S | 01/01/2019 |
| Società | Posizione | Fine |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale